Correlation Between GlaxoSmithKline PLC and Invesco Fundamental

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Invesco Fundamental at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Invesco Fundamental into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Invesco Fundamental Investment, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Invesco Fundamental and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Invesco Fundamental. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Invesco Fundamental.

Diversification Opportunities for GlaxoSmithKline PLC and Invesco Fundamental

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between GlaxoSmithKline and Invesco is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Invesco Fundamental Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco Fundamental and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Invesco Fundamental. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco Fundamental has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Invesco Fundamental go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Invesco Fundamental

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Invesco Fundamental. In addition to that, GlaxoSmithKline PLC is 4.26 times more volatile than Invesco Fundamental Investment. It trades about -0.3 of its total potential returns per unit of risk. Invesco Fundamental Investment is currently generating about 0.05 per unit of volatility. If you would invest  2,365  in Invesco Fundamental Investment on August 30, 2024 and sell it today you would earn a total of  8.00  from holding Invesco Fundamental Investment or generate 0.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Invesco Fundamental Investment

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Invesco Fundamental 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Fundamental Investment has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Invesco Fundamental is not utilizing all of its potentials. The new stock price disturbance, may contribute to mid-run losses for the stockholders.

GlaxoSmithKline PLC and Invesco Fundamental Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Invesco Fundamental

The main advantage of trading using opposite GlaxoSmithKline PLC and Invesco Fundamental positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Invesco Fundamental can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco Fundamental will offset losses from the drop in Invesco Fundamental's long position.
The idea behind GlaxoSmithKline PLC ADR and Invesco Fundamental Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance